VVOS RSI Chart
Last 7 days
8.0%
Last 30 days
-13.9%
Last 90 days
-56.4%
Trailing 12 Months
535.9%
Historical Charts for Stock Metrics
Year | Q1 | Q2 | Q3 | Q4 |
---|---|---|---|---|
2024 | 13.4M | 0 | 0 | 0 |
2023 | 16.2M | 15.4M | 14.5M | 13.8M |
2022 | 17.1M | 16.8M | 16.5M | 16.0M |
2021 | 13.3M | 14.5M | 15.8M | 16.9M |
2020 | 11.8M | 12.2M | 12.6M | 13.1M |
2019 | 0 | 0 | 0 | 11.4M |
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
Jun 20, 2023 | huntsman ronald kirk | bought | 7,420 | 0.53 | 14,000 | chief executive officer |
Jun 16, 2023 | huntsman ronald kirk | bought | 8,050 | 0.536667 | 15,000 | chief executive officer |
Jun 15, 2023 | huntsman ronald kirk | bought | 10.5 | 0.5 | 21.00 | chief executive officer |
Jun 14, 2023 | huntsman ronald kirk | bought | 4,900 | 0.49 | 10,000 | chief executive officer |
Dec 23, 2022 | huntsman ronald kirk | bought | 10,000 | 0.5 | 20,000 | chief executive officer |
Jun 01, 2022 | huntsman ronald kirk | bought | 7,320 | 1.83 | 4,000 | chief executive officer |
May 31, 2022 | huntsman ronald kirk | bought | 16,240 | 2.03 | 8,000 | chief executive officer |
Sep 21, 2021 | huntsman ronald kirk | bought | 21,550 | 4.31 | 5,000 | chief executive officer |
Aug 17, 2021 | huntsman ronald kirk | bought | 15,000 | 3.00 | 5,000 | chief executive officer |
May 25, 2021 | amman bradford k. | bought | 5,290 | 5.29 | 1,000 | chief financial officer |
Which funds bought or sold VVOS recently?
View All DetailsDatesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
May 17, 2024 | Kozak & Associates, Inc. | unchanged | - | -240 | 111 | -% |
May 15, 2024 | Tower Research Capital LLC (TRC) | added | 0.64 | -13,021 | 8,351 | -% |
May 15, 2024 | Royal Bank of Canada | unchanged | - | - | - | -% |
May 15, 2024 | MORGAN STANLEY | unchanged | - | -509 | 324 | -% |
May 15, 2024 | BANK OF AMERICA CORP /DE/ | new | - | 386 | 386 | -% |
May 15, 2024 | Steward Partners Investment Advisory, LLC | unchanged | - | -61.00 | 39.00 | -% |
May 15, 2024 | Schonfeld Strategic Advisors LLC | sold off | -100 | -623,244 | - | -% |
May 14, 2024 | Credit Agricole S A | unchanged | - | -231 | 63.00 | -% |
May 10, 2024 | BlackRock Inc. | sold off | -100 | -522 | - | -% |
May 10, 2024 | VANGUARD GROUP INC | unchanged | - | -80,506 | 51,097 | -% |
Unveiling Vivos Therapeutics, Inc.'s Major ShareHolders
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Peers (Alternatives to Vivos Therapeutics, Inc.)
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
ABT | 181.0B | 40.3B | 32.18 | 4.49 | ||||
BDX | 68.3B | 19.7B | 51.24 | 3.46 | ||||
ALGN | 20.4B | 3.9B | 44.2 | 5.22 | ||||
BAX | 18.0B | 14.9B | 6.79 | 1.21 | ||||
MID-CAP | ||||||||
ATR | 9.8B | 3.5B | 31.27 | 2.76 | ||||
HSIC | 9.6B | 12.5B | 24.63 | 0.77 | ||||
BIO | 8.4B | 2.6B | -26.02 | 3.22 | ||||
XRAY | 5.9B | 3.9B | -62.84 | 1.49 | ||||
AXNX | 3.4B | 387.1M | -216.3 | 8.9 | ||||
PDCO | 2.3B | 6.6B | 11.93 | 0.35 | ||||
SMALL-CAP | ||||||||
AHCO | 1.3B | 3.2B | -1.91 | 0.41 | ||||
ANIK | 376.6M | 169.3M | -4.9 | 2.23 | ||||
ANGO | 241.9M | 324.0M | -1.26 | 0.75 | ||||
APYX | 56.1M | 50.5M | -2.46 | 1.11 | ||||
AEMD | 1.0M | 3.7M | -0.09 | 0.28 |
Vivos Therapeutics, Inc. News
Income Statement (Quarterly) | |||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 |
Revenue | 5.3% | 3,419,000 | 3,248,000 | 3,301,000 | 3,395,000 | 3,857,000 | 3,950,000 | 4,246,000 | 4,184,000 | 3,644,000 | 4,394,000 | 4,546,000 | 4,497,000 | 3,448,000 | 3,306,703 | 3,291,602 | 3,271,188 | 3,196,507 | - |
Gross Profit | -0.1% | 1,937,000 | 1,938,000 | 1,898,000 | 2,098,000 | 2,337,000 | 2,384,000 | 2,496,000 | 2,588,000 | 2,551,000 | 3,107,000 | 3,183,000 | 3,624,000 | 2,690,000 | 2,688,189 | 2,582,418 | 2,726,342 | 2,416,051 | - |
Operating Expenses | -8.0% | 5,722,000 | 6,222,500 | 5,387,000 | 6,615,000 | 7,342,000 | 8,426,000 | 7,903,000 | 9,552,000 | 9,190,000 | 10,518,500 | 8,686,000 | 7,685,000 | 6,096,000 | 8,935,922 | 4,399,633 | 4,143,670 | 4,973,775 | - |
S&GA Expenses | 8.1% | 655,000 | 606,000 | 641,000 | 590,000 | 630,000 | 1,568,500 | 1,106,000 | 1,699,000 | 753,000 | 1,317,000 | 1,976,000 | 1,398,000 | 860,000 | 820,270 | 431,704 | 502,190 | 559,836 | - |
EBITDA Margin | 14.1% | -0.84 | -0.98 | -1.01 | -1.27 | -1.20 | -1.45 | -1.48 | -1.46 | -1.26 | -1.16 | -0.71 | -0.78 | -0.85 | -0.86 | -0.78 | -0.81 | -0.84 | - |
Interest Expenses | - | - | - | - | - | - | -2,000 | - | - | 2,000 | 1,631 | 9,488 | 251 | 5,000 | 17,218 | 16,992 | 18,067 | 43,723 | - |
Earnings Before Taxes | 11.6% | -3,763,000 | -4,259,000 | -2,093,000 | - | -1,703,000 | -6,088,500 | -5,434,000 | -6,992,000 | -5,331,000 | -7,393,000 | -5,453,000 | -4,043,000 | -3,399,000 | - | - | - | - | - |
EBT Margin | 13.7% | -0.88 | -1.02 | -1.06 | -1.31 | -1.25 | -1.49 | -1.53 | -1.50 | -1.30 | -1.20 | -0.76 | -0.83 | -0.91 | -0.92 | -0.85 | -0.88 | -0.91 | - |
Net Income | 10.8% | -3,800,000 | -4,259,000 | -2,093,000 | -5,528,000 | -1,703,000 | -6,088,500 | -5,434,000 | -6,992,000 | -5,331,000 | -7,393,000 | -5,453,000 | -4,043,000 | -3,399,000 | -6,249,593 | -1,813,168 | -1,413,672 | -2,580,567 | - |
Net Income Margin | -19.2% | -1.17 | -0.98 | -1.06 | -1.21 | -1.25 | -1.49 | -1.53 | -1.50 | -1.30 | -1.20 | -1.21 | -1.07 | -0.97 | -0.92 | -0.85 | -0.88 | -0.91 | - |
Free Cashflow | 6.9% | -2,667,000 | -2,865,000 | -2,956,000 | -3,104,000 | -3,778,000 | -3,200,000 | -5,987,000 | -5,122,000 | -6,202,000 | -4,504,000 | -4,454,000 | -5,050,000 | -4,123,000 | -3,713,041 | -686,445 | -958,400 | -442,114 | - |
Balance Sheet | ||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2019Q4 |
Assets | 10.0% | 11,804 | 10,730 | 10,317 | 13,749 | 17,100 | 13,720 | 18,400 | 24,375 | 29,556 | 33,689 | 41,024 | 46,156 | 21,954 | 25,327 | 7,552 |
Current Assets | 46.7% | 3,611 | 2,461 | 1,985 | 5,342 | 8,713 | 5,424 | 9,701 | 15,513 | 21,601 | 27,324 | 34,031 | 39,389 | 16,735 | 20,394 | 1,984 |
Cash Equivalents | 63.2% | 2,611 | 1,600 | 988 | 3,900 | 7,046 | 3,519 | 6,719 | 12,700 | 17,828 | 24,000 | 28,535 | 34,198 | 14,058 | 18,206 | 469 |
Net PPE | 0.5% | 3,332 | 3,314 | 3,283 | 3,267 | 3,157 | 3,082 | 3,044 | 3,109 | 2,913 | 2,825 | 2,601 | 2,291 | 1,058 | 872 | 1,140 |
Goodwill | 0% | 2,843 | 2,843 | 2,843 | 2,843 | 2,843 | 2,843 | 2,843 | 2,843 | 2,843 | 2,843 | 2,843 | 2,843 | 400 | 2,671 | 2,671 |
Liabilities | 9.0% | 11,222 | 10,300 | 10,271 | 11,600 | 10,107 | 8,919 | 8,545 | 9,536 | 8,500 | 8,150 | 8,555 | 9,673 | 7,613 | 8,410 | 9,178 |
Current Liabilities | 10.7% | 8,070 | 7,289 | 7,167 | 8,440 | 7,975 | 6,813 | 5,964 | 6,694 | 6,292 | 7,509 | 8,195 | 9,314 | 7,295 | 7,841 | 9,094 |
LT Debt, Current | - | - | - | - | - | - | - | - | - | - | 1,265 | 1,265 | 1,265 | 1,159 | 867 | 3,710 |
Shareholder's Equity | 41.6% | 582 | 411 | 46.00 | 2,106 | 6,993 | 4,801 | 9,855 | 14,839 | 21,039 | 25,539 | 32,469 | 36,479 | 14,340 | 16,917 | - |
Retained Earnings | -4.0% | -96,814 | -93,100 | -88,792 | -86,700 | -81,200 | -79,468 | -73,400 | -67,946 | -61,000 | -55,623 | -48,229 | -42,776 | -38,733 | -35,335 | -23,277 |
Additional Paid-In Capital | 4.2% | 97,396 | 93,462 | 88,838 | 88,802 | 88,161 | 84,269 | 83,233 | 82,783 | 81,991 | 81,162 | 80,697 | 79,258 | 53,073 | 52,250 | 20,334 |
Shares Outstanding | 48.9% | 2,731 | 1,834 | - | 29,929 | 29,929 | - | 23,012 | 21,233 | - | - | 20,826,499 | 19,482,056 | - | 18,209 | 12,444 |
Float | - | - | - | - | 15,300 | - | - | - | 23,200 | - | - | - | 88,300 | - | 73,000 | - |
Cashflow (Quarterly) | |||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 |
Cashflow From Operations | 6.8% | -2,516 | -2,700 | -2,802 | -2,859 | -3,539 | -3,000 | -5,887 | -4,618 | -6,082 | -4,122 | -4,013 | -3,739 | -3,861 | -3,618 | -674 | -950 | -436 | - |
Share Based Compensation | 92.8% | 293 | 152 | 189 | 459 | 306 | 775 | 350 | 662 | 609 | 463 | 1,113 | 648 | 434 | 826 | 429 | 565 | 352 | - |
Cashflow From Investing | 8.5% | -151 | -165 | -154 | -245 | -289 | -200 | -100 | -504 | -120 | -382 | -432 | -1,532 | -262 | -94.99 | -12.00 | -7.80 | -5.20 | - |
Cashflow From Financing | 1.9% | 3,635 | 3,568 | - | - | 7,355 | - | - | - | - | - | -1,174 | 25,366 | -25.00 | 20,369 | 1,823 | 1,265 | 80.00 | - |
Condensed Consolidated Statements of Operations (Unaudited) - USD ($) $ in Thousands | 3 Months Ended | ||||
---|---|---|---|---|---|
Mar. 31, 2024 | Mar. 31, 2023 | ||||
Revenue | |||||
Total revenue | $ 3,419 | $ 3,857 | |||
Cost of sales (exclusive of depreciation and amortization shown separately below) | 1,482 | 1,520 | |||
Gross profit | 1,937 | 2,337 | |||
Operating expenses | |||||
General and administrative | 4,921 | 6,537 | |||
Sales and marketing | 655 | 630 | |||
Depreciation and amortization | 146 | 175 | |||
Total operating expenses | 5,722 | 7,342 | |||
Operating loss | (3,785) | (5,005) | |||
Non-operating income (expense) | |||||
Other expense | (1) | 51 | |||
Excess warrant fair value | (6,453) | ||||
Change in fair value of warrant liability, net of issuance costs of $645 | 9,628 | ||||
Other income | 23 | 76 | |||
Loss before income taxes | (3,763) | (1,703) | |||
Net loss | $ (3,763) | $ (1,703) | |||
Net loss per share (basic) | $ (1.63) | $ (1.72) | |||
Net loss per share (diluted) | $ (1.63) | $ (1.72) | |||
Weighted average number of shares of Common Stock outstanding (basic) | 2,308,154 | 990,669 | |||
Weighted average number of shares of Common Stock outstanding (diluted) | 2,308,154 | 990,669 | |||
Product [Member] | |||||
Revenue | |||||
Total revenue | $ 1,674 | [1] | $ 1,772 | ||
Service [Member] | |||||
Revenue | |||||
Total revenue | $ 1,745 | $ 2,085 | |||
|
Condensed Consolidated Balance Sheets (Unaudited) - USD ($) $ in Thousands | Mar. 31, 2024 | Dec. 31, 2023 |
---|---|---|
Current assets | ||
Cash and cash equivalents | $ 2,611 | $ 1,643 |
Accounts receivable, net of allowance of $252 and $250, respectively | 525 | 202 |
Prepaid expenses and other current assets | 475 | 616 |
Total current assets | 3,611 | 2,461 |
Long-term assets | ||
Goodwill | 2,843 | 2,843 |
Property and equipment, net | 3,332 | 3,314 |
Operating lease right-of-use asset | 1,302 | 1,385 |
Intangible assets, net | 408 | 420 |
Deposits and other | 308 | 307 |
Total assets | 11,804 | 10,730 |
Current liabilities | ||
Accounts payable | 2,499 | 2,145 |
Accrued expenses | 2,466 | 2,334 |
Current portion of contract liabilities | 2,398 | 2,138 |
Current portion of operating lease liability | 483 | 474 |
Other current liabilities | 224 | 198 |
Total current liabilities | 8,070 | 7,289 |
Long-term liabilities | ||
Contract liabilities, net of current portion | 533 | 289 |
Employee retention credit liability | 1,220 | 1,220 |
Operating lease liability, net of current portion | 1,399 | 1,521 |
Total liabilities | 11,222 | 10,319 |
Commitments and contingencies (Note 12) | ||
Stockholders’ equity | ||
Preferred Stock, $0.0001 par value per share. Authorized 50,000,000 shares; no shares issued and outstanding | ||
Common Stock, $0.0001 par value per share. Authorized 200,000,000 shares; issued and outstanding 2,731,270 shares as of March 31, 2024 and 1,833,877 shares as of December 31, 2023 | ||
Additional paid-in capital | 97,396 | 93,462 |
Accumulated deficit | (96,814) | (93,051) |
Total stockholders’ equity | 582 | 411 |
Total liabilities and stockholders’ equity | $ 11,804 | $ 10,730 |